Newtopia Inc. announced the success of a partnership with Medtronic Canada and the collaboration with Eastern Health to proactively prevent, slow and reverse Type 2 diabetes burden in Newfoundland and Labrador through an innovative, value-based approach. The pilot program was based on Eastern Health's recognition of the need to improve health outcomes for approximately 30% of the population - nearly 175,000 Newfoundland and Labrador residents - who live with, or are at risk of developing, diabetes. Under a contract designed specifically around value-based payment triggers, participants in the trial received 1:1 dedicated health coaching delivered virtually using Newtopia's personalized lifestyle and habit change platform.

Weight loss trends among participants showed a decrease from a baseline of 3.5% of body weight at 6 months and 6.4% at 10 months. Among participants with two or more A1c test results, A1c declined by an average of 0.5, and 1.1 for those with an initial A1c of 9.0 or above. Outcomes were accompanied by impressive engagement levels of 81% among participants, further highlighting the effectiveness of Newtopia's humans-helping-humans approach amplified by technology.

The success of the pilot program led to recognition by the Canadian Diabetes Association with a presentation of an outcomes analysis at the 2022 Diabetes Canada/CSEM Professional Conference, as well as the publication of results in the Canadian Journal of Diabetes. Global experience demonstrates that the transition of healthcare systems towards better cost-of-care value in relation to improved health outcomes and experiences requires the collaboration of the health industry as a whole, as well as initiatives that demonstrate the power of value-based partnerships between public and private sectors. Given growing awareness in Canada of the need to intervene in social determinants of health, as well as the balance of community-based and hospital-based services, Newtopia's innovations with engagement- and outcomes-based economics make establishing value-based contracting simple and intuitive with the goals of increased patient participation, health and lifestyle improvements with clinically significant outcomes, and cost reductions.

The pilot program results are also consistent with Newtopia's recent receipt of the highest Full-Plus recognition from the Centers for Disease Control and Prevention for delivering a proven, highly effective alternative diabetes prevention program.